Workers at Connecticut’s Largest Cannabis Grow Facility Join Union

Workers at Connecticut’s largest cannabis cultivation facility have joined United Food and Commercial Workers Union (UFCW) Local 919, the News Times reports. More than 70 workers at CTPharma’s facility in Rocky Hill voted to join the union on June 13 and the contract was ratified later in the month. 

CTPharma is owned by Verano, which is based in Illinois. 

The CTPharma workers are the second cannabis cultivation facility employees to join a union in the state – in May workers at Advanced Grow Labs voted to join Local 919, becoming the first cannabis cultivation employees in the state to do so.   

In a statement, UFCW Director of Organizing Emily Sabo said the workers joined the union because they wanted “to make sure that they have a voice that matters at work and that this industry is equitable for the workers, too.”  

“So whatever that looks like, with how automation changes will end up affecting the cannabis industry inevitably, just like every other industry, they want to have those workplace protections and those conversations and the ability to talk about those things with their employer.” — Sabo via the News Times 

Under Connecticut law, cannabis business licensees are required to have a labor peace agreement in place. Sabo explained that while every cannabis business in the state is required to have such an agreement, that does not mean a union will form, though it’s more likely to happen.   

“A labor peace agreement means that an operator will remain neutral and fair if workers want to form a union,” she told the News Times. “In return, the union agrees and the workers are agreeing not to picket, no work stoppages, strikes, etc., in exchange for the neutrality.” 

The union includes workers in all areas of the facility. 

End


Study: Cannabis Legalization in Ohio Could Be Worth Up to $403M in Tax Revenues

A study published this month by Ohio State University researchers suggests that adult-use cannabis sales in the state could generate between $275 million and $403 million by the fifth year of operations.

The analysis, “What Tax Revenues Should Ohioans Expect If Ohio Legalizes Adult-Use Cannabis?,” uses cannabis tax data from Michigan fiscal year 2021 as its focal point for Ohio cannabis tax revenue estimates “given the demographic and tax structure similarities.”  

The researchers use three different scenarios for rate of diminishing retail sales growth through year five of an operational legal adult-use program; state population figures as the basis for calculating per capita cannabis tax revenue rates; and model for three different Ohio pricing scenarios. 

Ohio advocates are seeking to put the issue on 2024 ballots and earlier this month submitted an additional batch of petition signatures after state officials said they were short in their initial batch.  

State lawmakers have also introduced legislation to enact the reforms, but that bill has not been introduced in the full House and remains in the chamber’s Finance Committee. 

Ohio voters first considered adult-use cannabis legalization in 2015 but ultimately rejected the proposal, which had drawn criticism for containing monopoly-like elements that would have kept cannabis cultivation rights exclusive to a handful of anonymous donors.

End


Delta-8 THC Derived from CBD is Illegal, According to DEA Email

A letter written in 2021 by the U.S. Drug Enforcement Administration’s Drug & Chemical Evaluation Section Chief Terrence Boos has revealed that DEA considers delta-8 THC, when synthesized from CBD, to be federally illegal. The letter was revealed late last week by attorney Shane Pennington via his “On Drugs” Substack.

“Arriving at delta-8-THC by a chemical reaction starting from CBD makes the delta-8-THC synthetic and therefore, not exempted by the [Agriculture Improvement Act]. Any quantity of delta-8-THC obtained by chemical means is a controlled substance.” — Boos, via the “On Drugs” Substack

The Agriculture Improvement Act, better known as the 2018 Farm Bill, allowed states to implement their own hemp programs. Since then, companies selling hemp-derived cannabinoids have sprung up around the country, but some have gone even further in synthesizing the hemp-based cannabinoids — which are generally nonintoxicating — into more psychoactive cannabinoids such as delta-8 or even delta-9 THC.

The letter puts plainly what many experts have suspected for months — DEA communicated during a May 4 conference presentation that the agency supported adding all synthetic cannabinoids that contain THC, including hemp-derived delta-8 THC, to the list of federally controlled substances. Additionally, in February, Boos wrote to another attorney that minor cannabinoids including delta-8 THC-0 and delta-9 THC-0 are illegal because they can only be synthesized and do not appear in nature, Marijuana Moment reports.

Notably, delta-8 THC does appear naturally in cannabis plants but only in trace amounts, but the vast majority of consumer delta-8 products are made using delta-8 THC that was synthesized from hemp-derived CBD.

End


Lawsuit Seeks to End Connecticut’s Cannabis Programs

A lawsuit filed last week in Connecticut Superior Court is challenging cannabis legalization in the state and asking a judge to stop cannabis sales, CT News Junkie reports. The complaint was filed by the Stamford Neighborhoods Coalition and more than a dozen individual plaintiffs and names Mayor Caroline Simmons and the city’s Zoning Board as defendants. 

The group is seeking an injunction to ban cannabis business operations in Stamford and the state as a whole on the grounds that the 2021 law legalizing cannabis possession and commercial sales was preempted by the federal Controlled Substances Act.

In the complaint, attorney David Herz argued that “Under federal law anyone involved in the growing, manufacturing, distribution or dispensing, or possession with intent to manufacture, grow, distribute or dispense marijuana is marijuana trafficking subject to federal prosecution under the federal Controlled Substances Act.”

“It is therefore unconstitutional and can not be relied upon by the City of Stamford or its Zoning Board to permit the illegal enterprise that is every Cannabis business.” — Herz, in the complaint, via CT News Junkie

The lawsuit also claims that the social equity provisions in the cannabis law violate an equal rights provision of the state constitution. The law created a Social Equity Council intended to ensure that the retail market benefited the Connecticut communities most impacted by the enforcement of cannabis prohibition. The complaint refers to the creation of the council as a “scheme” that is “impermissibly selected based on race.”

“The purpose of the Social Equity Counsel is to entitle a certain set of people to exclusive public emoluments,” the lawsuit argues.

A Congressional Research Service report published in March found that while the federal government has taken a largely hands-off approach to cannabis reforms enacted by the states, “The Department of Justice (DOJ) has nonetheless reaffirmed that marijuana growth, possession, and trafficking remain crimes under federal law irrespective of states’ marijuana laws.”

“Federal law enforcement has generally focused its efforts on criminal networks involved in the illicit marijuana trade,” the report says.

Adult-use cannabis sales in Connecticut reached $13 million in July. 

End


Cannabis Industry Exchange-Traded Fund to Shut Down this Month

One of the leading exchange-traded funds in the cannabis space will see its final day of trading this month, CNBC reports. The Poseidon Dynamic Cannabis ETF, managed by AdvisorShares, plans to stop trading on August 25 and will liquidate assets and pay shareholders by September 1.   

In a statement to CNBC, co-founder Morgan Paxhia said the fund was not “immune to the broader macro-economic environment and, more specifically, the dramatic shift in investor sentiment that has impacted the cannabis industry.”

Poseidon Investment Management started in 2013 as one of the first cannabis-focused hedge funds in the U.S. but it has seen its ETF lose roughly 74% in value since it was founded, versus a 1.7% decline in the S&P 500, the report says. On Tuesday, the day of the closure announcement, it was trading at under $1.00 and its value has fallen 65% in the last year. 

The fund’s downturn is due, in part, to the U.S. government’s inaction on cannabis law reforms – it remains a Schedule I drug, and cannabis businesses still do not have access to traditional financial services. Additionally, cannabis wholesale prices have declined, and publicly-traded cannabis businesses have struggled to scale profits. State-legal cannabis companies, meanwhile, must also persevere through high excise taxes, additional tax complications from Section 280E of the Internal Revenue Code, and competition from the generally unregulated sale of hemp-derived THC products, as well as from the illicit cannabis marketplace.

Pure US Cannabis ETF, another fund in the cannabis industry managed by AdvisorShares, has also lost about 60% of its value in the last year. 

End


Combined Cannabis Sales in Missouri Top $123M in July

For the sixth consecutive month, combined medical and adult-use cannabis sales in Missouri topped $100 million, totaling $123.2 million in July, Greenway Magazine reports. Since the launch of medical cannabis sales in October 2020, cannabis sales in the state have exceeded $1.35 billion. 

Adult-use sales in July were $98.7 million while medical cannabis sales totaled $24.5 million. Combined sales in July represented a 1.57% increase over the previous month. 

This year, cannabis sales in the state are projected to exceed $1.4 billion; year-to-date adult-use sales have reached $542.70 million, while medical cannabis sales to July have totaled $209.8 million, the report says. 

Those projections, however, could be negatively impacted by a recent recall of nearly 63,000 products produced by Delta Extraction, LLC. The recall was implemented by the Missouri Division of Cannabis Regulation (DCR) on Monday because they were not tracked by METRC, the state’s seed-to-sale tracking system. DCR said in a press release that because METRC was not used, the agency could not “verify that the products came from marijuana grown in Missouri or that the product passed required testing prior to being sold at dispensaries.” DCR added that “no adverse reactions for this product have been reported” to the agency. 

End


Federal Appeals Court Rules Gun Ban for Cannabis Consumers Is Unconstitutional; DOJ Contests Decision

In a brief filed on Friday, the Justice Department informed a federal appeals court that it believes a separate court’s recent ruling that the federal ban on cannabis consumers owning or possessing firearms is unconstitutional was “incorrectly decided,” Marijuana Moment reports. The DOJ shared its opinion with the U.S. Court of Appeals for the Eleventh Circuit while preparing for another lawsuit related to the gun ban for cannabis consumers.

The decision in question — which was announced last week by the U.S. Court of Appeals for the Fifth Circuit — marked the latest in a string of victories for advocates seeking to normalize gun ownership laws for cannabis consumers. District courts have also ruled that the ban on cannabis consumers owning guns violates the Second Amendment but the Fifth Circuit is the most powerful court yet to reach the decision.

According to the report, legal arguments for ending the ban generally hinge on a 2022 Supreme Court ruling that found restrictions on firearms must be consistent with the historical context of the Second Amendment.

In the Fifth Circuit’s ruling last week, U.S. Circuit Judge Jerry Smith wrote that U.S. drug laws have historically “regulated the combination of guns and intoxicating substances.”

“But at no point in the 18th or 19th century did the government disarm individuals who used drugs or alcohol at one time from possessing guns at another. In short, our history and tradition may support some limits on an intoxicated person’s right to carry a weapon, but it does not justify disarming a sober citizen based exclusively on his past drug usage.” — Smith, excerpt from the opinion for the U.S. Court of Appeals for the Fifth Circuit

If the U.S. Court of Appeals for the Eleventh Circuit were to uphold the gun ownership ban — contradicting the decision by the Fifth Circuit court — it could set the stage for the Supreme Court to intervene, the report said.

End


Fort Lauderdale and Aspen Public Relations Firm Durée & Company Wins ‘Best Use of PR’ Award at Cannabis Marketing Association Seven Awards in Denver

Durée & Company is Sole Winner in PR Category for its Work on Columbia Care/Cannabist’s Launch in West Virginia, a New Cannabis Market

Aspen, Colo. — August 15, 2023 — Award-winning Fort Lauderdale- and Aspen-based full-service public relations and marketing agency Durée & Company, Inc. is the sole winner of the inaugural Cannabis Marketing Association Seven Awards’ “Best Use of PR” award. The firm won for its work with Columbia Care/Cannabist’s Launch in West Virginia, a new cannabis market.

Firm President and Founder Durée Ross accepted the award in person at the Cannabis Marketing Association Seven Awards Show, held at the 2023 Cannabis Marketing Summit in Denver, Colorado. Ross was present at the conference to deliver a presentation on crisis communication, by way of special invite from the event organizers. Launched in 2023, Cannabis Marketing Association’s Seven Awards aim to highlight and uplift successful marketing campaigns that are advancing the image of cannabis within the regulated industry. There are 20 unique award categories, including “Best Use of PR”, which focuses on public relations campaigns and crisis communications. Entries were judged by independent jurors who considered a number of criteria in making their final selections.

Durée & Company’s established cannabis practice and multifaceted work with brands in the cannabis space laid the groundwork for a highly successful partnership with multi-state operator (MSO) Columbia Care and the expansion of its Cannabist brand in a number of U.S. markets. The PR/awareness campaign, with a goal to increase medical card holders as well as advancement of medical cannabis use in West Virginia, took place from February–March 2022.

With Cannabist’s plans to enter the new medical market of West Virginia in five cities across the state, the firm devised a campaign to position Cannabist as the go-to resource for a friendly, uncomplicated shopping experience for medical marijuana patients. Because medical cannabis was a new industry in the state, and Cannabist was one of the first dispensaries in each county it serves, the firm worked to dispel any preconceived notions among media and the public, and communicate how Cannabist is committed to the local communities it serves.

Among other efforts, the firm proactively pitched media for story opportunities and publicized educational events to help patients better understand the state’s medical cannabis program, how to obtain a medical card, how to select products, and connect prospective patients with licensed medical providers.

Durée & Company garnered more than 64 million media impressions in just over two months. The media coverage helped to establish Columbia Care/Cannabist as a leading player in the cannabis industry in West Virginia, and helped raise awareness about the benefits of cannabis products and to educate the public about the safety and legality of using them.

“We are honored to be the sole recipient of Cannabis Marketing Association Seven Awards’ ‘Best Use of PR’ award,” said Ross. “Working to launch this new cannabis market was an opportunity for us to use our cannabis PR expertise to lay the groundwork in a state that is newly medical.

“This award is a testament to our established and esteemed cannabis PR practice, through which we work with clients from multi-state operators to labs to cannabis lawyers and more, up and down the cannabis supply chain,” she continued.

For more information about Durée & Company’s cannabis practice, visit its microsite https://cannabismarketingpr.com/, dedicated to its practice providing PR and marketing for clients in the booming CBD, hemp and cannabis industries. Also for more information, call the firm’s Fort Lauderdale office at 954-723-9350, or its Aspen office at 970-452-2195.

About Durée & Company, Inc.
Founded in 1999, Durée & Company is a full-service, well-respected and highly creative public relations and marketing agency serving a diverse client base of local, national and international consumer brands, landmark industries, business leaders and philanthropists from its offices in Fort Lauderdale, Florida and Aspen, Colorado. Practice areas include nonprofit, hospitality, business, lifestyle, health and wellness, legal, real estate, yacht and marine as well as cannabis, psychedelics, and other emerging industries. Durée & Company is a member of some of the nation’s most elite professional organizations including PR Boutiques International™ (PRBI), The Florida Hemp Council, Cannabis Marketing Association and is a corporate partner of Cannabis LAB. To learn more, call 954-723-9350; go to dureeandcompany.com; cannabismarketingpr.com; or psychedelicpr.com. Join the social conversation and follow Durée & Company on Facebook, Instagram, TwitterYouTube and LinkedIn at @DureeCoPR.

# # #

End


Nearly 63k Cannabis Products Recalled in Missouri

The Missouri Division of Cannabis Regulation (DCR) on Monday issued a recall of products manufactured by Delta Extraction, LLC because they were not tracked by METRC, the state’s seed-to-sale tracking system.

DCR said in a press release that because METRC was not used, the agency could not “verify that the products came from marijuana grown in Missouri or that the product passed required testing prior to being sold at dispensaries.” DCR added that “no adverse reactions for this product have been reported” to the agency.

The recall covers nearly 62,800 products produced by Delta extraction, according to the list provided by state regulators.

The recall notice followed a hearing at the Administrative Hearing Commission in which Delta Extraction challenged the state’s immediate suspension of its license, according to a St. Louis Post-Dispatch report. Earlier this month, state cannabis regulators suspended the licenses of three cannabis facilities over “potential product safety concerns,” according to the Post-Dispatch.

During the hearing, Jack Maritz, a manager for Delta Extractions testified that during the distillation process, hemp-derived THCa may be used from out-of-state sources. Delta argued that previous regulations allowed the out-of-state hemp product to be used, while the state countered that using out-of-state products is not allowed and that more recent regulations clarified that.

End


Cannabis Beverage Bar Opens in South Carolina

A bar specializing in nonalcoholic, cannabis-infused cocktails opened last week on South Carolina’s James Island, WCBD reports. The ‘Cannabis Dry Bar’ is within the Charleston Hemp Collective and is in partnership with High Rise Beverages.

Co-owner Chris Long told WCBD that he quit drinking alcohol six years ago and after that, “wasn’t able to have some of the social…enjoyment” he had when going to bars.

“I feel like this space has just created that social environment where you can come out and enjoy yourself again without having the alcohol aspect.” — Long to WCBD

High Rise Beverage Founder Matt Skinner told BevNet in March that the goal of the dry bar is “to create a more elevated experience for those seeking nonalcoholic alternatives.”

The bar serves a variety of spirit-free cocktails, combining natural ingredients with the customer’s choice of CBD, delta-8 THC, or delta-9 THC. Patrons can also add THC-infused gummies to their order.

Skinner described the bar to Eater as “cannabis themed” but “a wellness bar.”

“We’re going through a big NA movement right now,” Skinner said. “A lot of Generation Z isn’t drinking anymore, and we are getting more and more educated on the medicinal benefits of the hemp plant.”

The business is the first of its kind in the state.

End


Nebraska Gov. Rejects Bid to Reform Rules Around Cannabis Use for Law Enforcement Applicants

Nebraska Gov. Jim Pillen (R) has nixed a proposal that would have reduced the number of months that a law enforcement officer recruit could have used cannabis before training from 24 months to 12 months, the Nebraska Examiner reports. The new rules were proposed by the Police Standards Advisory Council, but Pillen said the reforms would be seen as “watering down” the standards. 

The council had recommended the changes as part of its effort to qualify applicants to work in law enforcement in Nebraska. 

In a letter last month rejecting the proposal, Pillen said he didn’t think it was “prudent” to adopt the change without data showing “a significant number” of applicants are being rejected due to the current drug-use standards, the report says.   

“It is therefore imperative that we have the necessary data before making a policy change that could be perceived as watering down the standards to become a law enforcement officer in the State of Nebraska.” — Pillen, in the letter, via the Examiner 

Brian Jackson, the president of the council and an assistant chief with the Lincoln Police Department, told the Examiner that he and others are working on obtaining and providing the necessary data to Pillen. The rules also disqualify applicants that have used a “dangerous drug” within the last five years. Jackson said that it was impossible to know how many people decided not to apply for law enforcement positions after learning about the drug use rules. 

End


Cannabis Sales in Michigan Reach All-Time Monthly Record in July of $275M

Combined cannabis sales in Michigan reached a new record in July, totaling $275 million, according to Cannabis Regulatory Agency (CRA) data. Adult-use sales in July topped $270 million – a 43.3% increase from June 2022. 

The total puts cannabis sales in Michigan on pace for $3 billion this year. If it reaches that goal, Michigan would join California as the only states to net $3 billion in annual cannabis sales, according to MI Tech News. Through July, adult-use sales in the state neared $1.6 billion, according to CRA data. 

Through the first seven months of the year, Michigan’s dispensaries sold more than 571,000 pounds of cannabis flower, combined for adult and medical use. The total represents a 107% increase from the approximately 276,000 pounds sold during the first seven months of 2022, according to the CRA data. 

Through July, cannabis sales by month averaged $243.3 million. 

Flower comprised the bulk of adult-use sales in Michigan last month, topping $126,000, followed by vape cartridges ($51.8 million), infused edibles ($27.3 million), inhalable compound concentrates ($24.7 million), shake and trim ($23.4 million), and concentrates ($15.1 million).

As of July 31, Michigan has 2,080 active cannabis licensees, including 704 adult-use cannabis retailers. Michigan legalized cannabis for adult-use in 2018. 

End


California Officials Eradicate 67k+ Plants in ‘Largest Ever’ Cannabis Enforcement Action

California’s United Cannabis Enforcement Taskforce (UCETF) last month eradicated 67,045 illegally cultivated cannabis plants and seized 8,019 pounds of processed cannabis as part of its crackdown on illicit cannabis operations. In all, the plants and processed cannabis were worth an estimated $68.5 million 

The operation, from July 11-13, included 24 search warrants and also uncovered a dozen firearms. The warrants were served in Whitney Creek, Harry Cash, and Shasta Vistas areas in Siskiyou County. The UCETF describe the enforcement action as its “largest ever.”  

“The operation targeted illegal cannabis cultivation sites that threaten the environment, workers, and other members of the public,” the UCETF said in a press release. “The sites in question were associated with suspected environmental violations, including the use of unlawful pesticides and other toxic chemicals. These dangerous chemicals not only degrade California’s natural resources, but also endanger workers and others exposed to them.” 

Gov. Gavin Newsom (D) created the multiagency task force in October 2022. In May, the UCETF said that from January 1 through March 30 it had seized more than $52 million in unlicensed cannabis and cannabis products despite serving nine fewer warrants than the previous quarter.  

From October 2022 to May 2023, the UCETF seized $84,652,875 in unlicensed cannabis through the serving of 51 search warrants, while eradicating 82,216 plants and seizing 13 firearms. 

End


South Dakota AG Releases Draft Ballot Explanation for Cannabis Legalization Bid

South Dakota Attorney General Marty Jackley last week released a draft ballot explanation for a proposed constitutional amendment to legalize cannabis in the state. The proposal would allow adults 21-and-older to “possess, grow, sell, ingest, and distribute” cannabis and related paraphernalia.

Under the measure, adults could possess up to two ounces of flower and cultivate six plants, with a maximum of 12 plants per household. The document explains that, under the proposal, driving under the influence of cannabis would remain illegal, cannabis possession and use would be restricted at schools and “where tobacco is prohibited,” employers could restrict cannabis use by employees, and property owners could regulate cannabis use.

The statement explains that the proposal would affect neither state hemp nor medical cannabis laws in the state and that “judicial or legislative clarification of this measure may be necessary.”

The measure requires 17,509 signatures to appear on the 2024 ballot. Public comments on the proposal will be accepted until August 21. The final explanation is due to the secretary of state by August 31.

During the 2022 midterm elections, South Dakota voters rejected a similar proposal 53% to 47%. It marked the second time voters in the state voted down the reforms, rejecting a legalization ballot question in 2018.

A poll by the School of American and Global Studies at South Dakota State University released in April found voters were split on the reforms with 30% of respondents saying they “strongly” supported broad cannabis legalization, while 19% “somewhat” backed adult-use legalization. Another 30% “strongly” opposed the reforms, with 11% “somewhat” opposed, while just 10% had no opinion.

End


Alabama Awards New Medical Cannabis Licenses

The Alabama Medical Cannabis Commission (AMMC) on Thursday voided all previously awarded licenses and awarded new ones, WPMI reports. The commission also outlined the errors in the scoring and evaluation of first round licensees which led to the awarding of new permits. 

The AMMC awarded five integrated facility licenses, seven cultivator licenses, four processor licenses, four dispensary licenses, and five secure transporter licenses.  

Applicants who were awarded a license now have 14 days to submit the appropriate license fee and any applicant who has been denied a license may seek an investigative hearing before the AMCC to seek reconsideration of the denial. 

The University of South Alabama was responsible for scoring the medical cannabis license applications but in June the AMCC paused issuing the licenses due to inconsistencies in scoring data tabulation. On Thursday, the AMCC outlined the errors which, according to a WBRC report, included:  

  • A scorer hitting the “submit” button twice for one integrated license, which doubled their score and created errors in the average scores. 
  • Evaluators incorrectly applying the wrong weight to every applicant score in all categories. 
  • Scores in the processor category were sorted/averaged by the evaluator, not the applicant. 
  • Quantitative and qualitative scores were inconsistent in all categories, forcing some scoring changes. 
  • Data-entry errors: some evaluators mis-keyed the numbers and had to be contacted by email to give the correct data, and some of the data they gave was applied to the wrong applicant or not at all. 

The University of South Alabama says it fixed all of the errors and had independent accounting firm KMPG verify the new scoring data, and now is confident in the numbers it’s given the AMCC. 

End


New Mexico AG Investigating Alleged Wage Theft and Human Trafficking at Cannabis Facility

The New Mexico Attorney General’s office is investigating a cannabis facility for alleged wage theft and human or labor trafficking, KOB 4 reports. While the AG’s office has confirmed the investigation, no arrests have been made.  

“We can confirm that the New Mexico Attorney General’s Office is investigating allegations of potential wage theft and human or labor trafficking at a cannabis cultivation facility in Torrance County. Our special agents, along with state and federal law enforcement partners from multiple agencies, are currently evaluating evidence recently recovered from the facility to determine if there have been any violations of the law. This is an open and active investigation.” — New Mexico Attorney General’s office, in a statement, via KOB 4 

According to the report, there were several signs written in both English and Mandarin at the facility and several Chinese people were transported to Albuquerque for medical care.  

One of the workers, through a translator, told KOB 4 that the raid was a “mistake.”  

“They did have lots of people come over, but they were actually thinking the other, some other people were here, but anyway, it comes out to be a mistake,” the worker said, “so they already leave, so everybody fine, no problem, everybody – nobody arrested or anything so, that’s it.” 

Neither the Torrance County Sheriff’s Office nor Cannabis Control Division have commented on the raid or allegations. 

End


Connecticut Adult-Use Cannabis Sales Reach $13M in July; Medical Sales Decline

Adult-use cannabis sales in Connecticut reached $13 million in July, while medical cannabis sales totaled $10.6 million, according to Department of Consumer Protection (DCP) data. In July, adult-use consumers purchased 324,177 products, while medical cannabis patients purchased 279,240 products.  

The average product price for adult-use products in July was $39.92 while the average price for medical cannabis products was $39.66. More than half of all sales – 52% – were flower, while vapes comprised 31% of sales and edible products represented 11% of sales. 

Adult-use sales in Connecticut have increased every month since sales launched in January. From June to July, adult-use sales increased by about $500,000 while medical cannabis sales decreased from about $11.4 million to $10.6 million over the same period.

So far this year, dispensaries in Connecticut have recorded about $68.9 million in adult-use sales and about $76.5 million in medical cannabis sales. According to DCP data, medical cannabis sales had been higher in the first four months adult-use cannabis was available for sale in the state; however, adult-use sales have exceeded medical cannabis sales in each of the last three months. 

Medical cannabis sales are exempt from sales and excise taxes. Transaction limits of 7 grams of raw flower or the equivalent remain in effect for all adult-use purchases, while medical cannabis patients may purchase up to 5 ounces per month and are not subject to individual transaction limits. 

End


New Hampshire to Study State-Owned Cannabis Retail System

New Hampshire Gov. Chris Sununu (R) on Tuesday signed the bill to create a cannabis legalization study commission, the New Hampshire Bulletin reports. The commission will evaluate how, and whether, cannabis could be sold through state-owned shops rather than private retailers. 

Cannabis use and possession is currently not legal in New Hampshire. In 2017, the state decriminalized possession of up to three-quarters of an ounce and anyone caught with less than that may be fined but not arrested.   

Sununu, who is not running for reelection next year, has long opposed cannabis legalization reforms in the state but in May said he would sign a legalization proposal into law if the bill included government control of sales, like how the state handles liquor sales. Were the state to approve such a system, New Hampshire would be the only state in the country to sell cannabis at state-run shops. Sununu has criticized nearby Maine and Massachusetts for, what he calls, “Marijuana Miles” or high concentrations of cannabis dispensaries. 

The commission will include five senators and five House representatives, as well as members representing the Attorney General’s Office; the New Hampshire Association of Chiefs of Police; the New Hampshire Bankers Association; the New Hampshire Liquor Commission; the American Civil Liberties Union; the New Hampshire Medical Society; and Communities for Alcohol and Drug-Free Youth. The commission will be required to consult with the state’s Alternative Treatment Centers, which currently dispense medical cannabis in the state, and the New Hampshire Cannabis Association, which has advocated for broad legalization. 

Under the law, the commission must file a report with its findings and recommendations by December 1.   

End


New York’s First Cannabis Growers Showcase Opens Today

New York’s first “Cannabis Growers Showcase” is set to open today in a municipal parking lot in New Paltz, the Times-Union reports. The showcases are similar to a farmer’s market and New York is the first and only state to allow cannabis sales via such a program.  

Office of Cannabis Management (OCM) officials said the event will operate weekly for the rest of the year or until the first retail cannabis store opens in New Paltz. The showcase is being organized by High Falls Canna, a family-owned cannabis cultivation company, and will feature products from four farms and a processor. 

Rick Weissman, High Falls Canna founder and president, told the Times-Union that his company has distributed products to a handful of retail dispensaries but that they still have “quite a bit to sell” and thousands more plants in the ground this year. He said they are participating because they “want the ability to sell” the product they grew last year. 

New York regulators approved the showcases last month as the state has been slow to license retailers, leaving growers and processors with excess product. The logjam could get worse as a state Supreme Court justice on Monday temporarily blocked the state from issuing and processing of new retail cannabis licenses following a lawsuit by veterans who claim that officials have failed to follow social equity provisions in the state’s cannabis legalization law.  

End


Gallup Poll: Half of Americans Have Tried Cannabis

Half of Americans have tried cannabis at some point, according to a new Gallup poll. Another 17% of those polled said they “smoke marijuana” – a new high recorded by the pollster but similar to the 16% found in the Gallup Consumption Habits survey a year ago.   

The proportion of Americans who say they smoke cannabis has more than doubled since 2013, when Gallup first asked the question, when 7% of respondents said they did. Between 1969 and 1977, the number of Americans who said they had tried cannabis jumped 20 percentage points, from 4% to 24% and the share rose another nine points, to 33%, by 1985, but then stalled at under 40% until 2015, when it rose to 44%. It remained at about that level through 2019 but then ticked up to 49% in 2021. 

Over that same period, Gallup recorded a significant increase in the U.S. public’s support for cannabis legalization, which has grown from 12% in 1969 to 68% today. 

The survey found that a majority of Democrats (57%) and independents (52%) had tried cannabis at some point, compared to 39% of Republicans.  

According to the poll, current use is highest among adults aged 18 to 34 – at 29% – and the cohort is more than three times as likely as adults 55-and-older (9%) to be current cannabis consumers. Current use among adults aged 35-54 (17%) matches the national average. 

Similar percentages of men and women say they consume cannabis, while adults without a college degree are about twice as likely as college graduates to smoke it. Democrats (21%) are nearly twice as likely as Republicans (12%) to smoke cannabis, while independents’ use (17%) falls in between. 

The majority of respondents said they are “not too” (32%) or “not at all concerned” about the effects of cannabis on adults (23%), while less than half said they are “very” (19%) or “somewhat concerned” (26%). Respondents were more likely to express concerns about cannabis’ effects on young adults or teens, with 40% saying they are “very” concerned and 35% saying they are “somewhat” concerned.   

End


Adult-Use Cannabis Sales in Maine Set Another Record in July

Adult-use cannabis sales in Maine set another new record in July, totaling $20.9 million, according to Maine Office of Cannabis Policy data. The previous record of $18.4 million was achieved in June, which surpassed the then-record $17.4 million total realized in May. 

In all, Maine dispensaries completed 360,886 transactions in July; about 40,000 more transactions than the previous month. 

Flower comprised the bulk of sales at Maine dispensaries last month with just over $12.2 million in sales. Infused products were the second most popular category with $3.5 million in sales, while concentrates represented $5.1 million in sales. 

The average price per gram in July was $7.79. Which was up slightly from June’s average price of $7.69. 

So far this year, Maine dispensaries have completed 2,033,596 transactions, totaling $118.3 million, according to OCP data. 

John Hudak, director of Maine’s Office of Cannabis Policy, told Maine Public Radio that customers are getting “comfortable with the businesses across Maine, in terms of how they’re conducting themselves and the products that they’re putting on their shelves.” 

“People see the products that are on the shelves in Maine as ones that meet their needs,” he said. 

There are currently 222 licensed cannabis retailers, 148 cultivators, 115 manufacturers, and four testing labs currently operating in the state. 

End


New York Judge Halts Cannabis Licensing After Lawsuit by Military Veterans

A New York Supreme Court justice on Monday temporarily blocked state officials from issuing retail cannabis licenses following a lawsuit by military veterans who claim the state is not following the cannabis law’s social equity provisions, the Associated Press reports. 

The order by Justice Kevin Bryant also prohibits the Office of Cannabis Management (OCM) from processing adult-use licenses.  

The veterans’ lawsuit argues that the OCM created a licensing system that runs afoul of the state’s adult-use cannabis law and improperly limits initial licenses to people with cannabis convictions rather than a wider category of social equity applicants. The lawsuit claims that the cannabis regulators overstepped their authority by creating the licensing category for people with convictions because that decision was not approved by the Legislature and that the decision violates the state constitution.   

Under the law, social equity applicants are defined as people from communities disproportionately impacted by the enforcement of cannabis prohibition, ethnic minority groups, women-owned businesses, distressed farmers, and service-disabled military veterans. The MRTA initially set aside 150 CAURD licenses; however, last month OCM approved an additional 212 CAURD licenses, bringing the total to 463.   

In a court filing, the attorney general’s office cautioned that halting the program will hurt retailers financially who are spending money to set up shop under provisional licenses. 

Oral arguments in the case are scheduled for Friday. 

End


Tilray Brands Acquires 8 Beer and Beverage Brands from Anheuser-Busch

Cannabis company Tilray Brands Inc. on Monday acquired eight beer and beverage brands from Anheuser-Busch, including Shock Top, Breckenridge Brewery, Blue Point Brewing Company, 10 Barrel Brewing Company, Redhook Brewery, Widmer Brothers Brewing, Square Mile Cider Company, and HiBall Energy. 

The deal includes current employees, breweries, and brewpubs associated with the brands and is expected to generate pro forma revenue of $250 million. 

The expected sales volume of the acquired brands will elevate Tilray Brands to the fifth largest craft beer business position in the U.S., up from the ninth, with current brands SweetWater Brewing Company, Montauk Brewing Company, Alpine Beer Company, and Green Flash Brewing Company.  

In a statement, Irwin D. Simon, chairman and CEO of Tilray Brands, said the deal solidifies the company’s “national leadership position and share in the U.S. craft brewing market and marks a major step forward” in its diversification strategy.  

“We are excited to work with the teams behind these iconic brands that command great consumer loyalty and have a history of delivering strong award-winning products with tremendous growth opportunities. Tilray is fully committed to invest in and champion the future of the U.S. craft beer industry by fueling new innovation that excites and further accelerates the growth of its consumer base.” — Simon in a press release 

Simon added that once the U.S. legalizes cannabis federally, the company will use its “leadership position in the craft beer industry” and “wide distribution network and portfolio of beloved beverage and wellness brands to include THC-based products and maximize all commercial opportunities.”  

Ty Gilmore, president for U.S. Beer at Tilray Brands, said, with the transaction, the company’s beer business “is expected to triple in size from 4 million cases to 12 million cases annually.” 

“Looking ahead,” Gilmore said, “we will further capitalize on the potential of these brands through product innovation, retailer partnerships and expanded distribution into key markets, including the Pacific Northwest and California.” 

The purchase price will be paid in all cash and the transaction is expected to close in 2023.

End


Cannabis Retailers Association of Vermont Announces Two-Day Music Festival Higher Calling to Support Cannabis Businesses

The Group Hopes the Superb Lineup Will Help Raise Significant Funds for Businesses Impacted by the Recent Flooding

Winooski, Vermont – The Cannabis Retailers Association of Vermont (CRAV) announced a two-day music festival – Higher Calling – that will be a fundraiser for cannabis businesses in Vermont. On July 10th, Vermont suffered from devastating flooding that has affected businesses across the state including numerous cannabis businesses. CRAV is currently seeking sponsors for the event which will consist of two days of both national and local performers as well as numerous other activities and entertainment.

CRAV is working to cover the expenses of Higher Calling with sponsorship funding. If they are able to raise more money than is necessary to cover the expenses, any excess sponsorship revenue will go directly to cannabis businesses impacted by the recent flooding. In addition to those funds, CRAV will contribute a minimum of 50 percent of the ticket sales to the Higher Calling fund. They are expecting at least 1500 people to attend the two-day music festival.

“We had been planning this music festival for weeks but once the flooding occurred we immediately shifted gears, knowing our community was going to need financial support. Between our pre-roll fundraiser and the music festival we hope to raise at least $150,000 for the people in our community who are trying to recover and get back to business after suffering significant losses due to flooding” said Todd Bailey executive director of CRAV.

The organization launched its Higher Calling fund and subsequent efforts last week starting with a pre-roll fundraiser. Participating retailers will contribute funds received by offering the profits from the pre-rolls going back to the fund to be distributed to qualified cannabis businesses. The Higher Calling music festival will be the culmination of these efforts and will take place on September 15 and 16 at Pransky Farm in Cabot, Vermont. Zenbarn – located in Waterbury, Vermont – will produce the music festival.

“We had musicians from around the country asking us how they could help… even though it was last minute we’ve had artists adjust their busy schedules to support this cause” – Noah Fishman, Zenbarn

In working with Zenbarn as well as Loose Leaf Talent Agency, CRAV has secured a spectacular and diverse line-up that will appeal to music lovers alike. Performances throughout the weekend include, long-time and legendary funk legends, The Motet as well as the eclectic, genre-bending lespecial on Friday night. Saturday will feature the NYC based and internationally touring Bluegrass/HipHop band, Ganstagrass as well as MTV VMA Award winner, Supaman, a one of a kind hip hop artist who stands true to his Native Culture. Marcus Rezak’s Shred is Dead feat. members of Cool Cool Cool, Particle and more, round out the evening with Gentleman Brawlers, La Lovo, as well other Vermont local talent to supply amazing entertainment throughout the entire day.

Tickets are on sale now at Seven Days Tickets for $50 for Friday night only, $85 for Saturday only and $125 for both days. All the ticket prices include camping.

Recovery from the devastating flooding on July 10th in Vermont is still ongoing. It may be several more weeks before many of the businesses in the state can reopen.

“The North Branch was cresting and we needed to drive to safety before we could save everything. We have received dozens of emails, calls and texts from our customers, and friends and partners in the cannabis community, offering help…even when some are facing their own challenges and losses. That has been the silver lining…knowing we are part of a caring community that looks out after each other. In order for us to get back to business and serve our customers we’ve opened a temporary location at the Central Vermont Marketplace formerly known as the Berlin Mall,” aaid Lauren Andrews, owner of Capital Cannabis in Montpelier.

To learn more about the event, the pre-roll fundraiser or CRAV, you can visit their website at CRVT.org. Or to buy tickets go to: Higher Calling Tickets

About CRAV
The Cannabis Retailers Association of Vermont’s mission is to create a thriving, diverse and sustainable cannabis industry in the state of Vermont that supports our working landscape and small business owners while providing the highest quality products possible to our customers from near and far. And help ensure Vermont becomes a destination for the best cannabis products in the world.

End